Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10032154 | 0.87 | — | — | |
| SCHEMBL11803871 | 0.87 | — | — | |
| SCHEMBL16925899 | 0.85 | — | — | |
| SCHEMBL6885012 | 0.85 | — | — | |
| SCHEMBL23735554 | 0.84 | CYP1A2 (0.35) | ALDH1A1SMN1; SMN2RECQLNOTUMLMNA | |
| SCHEMBL21695702 | 0.84 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2RECQLNOTUM | |
| SCHEMBL10042 | 0.82 | — | — | |
| SCHEMBL8891640 | 0.80 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2RECQLKDM4EMAPT | |
| SCHEMBL18410285 | 0.80 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2RECQL | |
| SCHEMBL23676967 | 0.80 | MEN1 (0.36) | ALDH1A1SMN1; SMN2NOTUMPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4245751-A1 | SEMICARBAZIDE COMPOSITION AND AQUEOUS COATING COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2023-09-20 | — | — | EP | disclosed |
| US-20150291831-A1 | SEMICARBAZIDE COMPOSITION, METHOD FOR PRODUCING SEMICARBAZIDE COMPOSITION, AQUEOUS POLYMER COMPOSITION AND COMPOSITE | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-10-15 | — | — | US | disclosed |
| US-5731141-A | HIGH TEMPERATURE, HIGH SPEED, LOW FOG | IMATION CORP. (US) | 1998-03-24 | — | — | US | disclosed |
| EP-0749038-A1 | Light-sensitive photographic materials comprising tabular silver halide grains and azodicarbonamide derivatives | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291831-A1 | SEMICARBAZIDE COMPOSITION, METHOD FOR PRODUCING SEMICARBAZIDE COMPOSITION, AQUEOUS POLYMER COMPOSITION AND COMPOSITE | C9, C5, BRD2 | ALDH1A1 1195/4885SMN1; SMN2 1642/4885RECQL 1855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.